| Title | Neoplasma : journal of experimental and clinical oncology / Cancer Research Institute of the Slovak Academy of Sciences
|
|---|
| Year, No. | Vol. 69, no. 5, rok 2022
|
|---|
| ISSN | 0028-2685
|
|---|
| Issue data | Bratislava : AEPress, 2022
|
|---|
| Phys.des. | s. 995-1252
|
|---|
| Collective Record/Entry | Neoplasma
|
|---|
| Language | English
|
|---|
| Country | Slovakia
|
|---|
| Copy count | 2, currently available 0, at library only 2
|
|---|
| Database | PERIODIKÁ - Prijaté čísla
|
|---|
| Content | Preoperative circulating fibrinogen to albumin ratio in predicting 5-year prognosis of oral cancer radical surgery / / Hong Zhu ... [et al.]
|
|---|
| Predictive and prognostic impact of the different features of tumor budding in stage II colorectal cancer / / Yi-Tong Wang ... [et al.]
|
|---|
| Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma / / Ju-Xian Tang ... [et al.]
|
|---|
| XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis / / Mei-Jing Zhang ... [et al.]
|
|---|
| Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma / / We-Chen Gong ... [et al.]
|
|---|
| Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid.. / Qiao-Xia Zhang ... [et al.]
|
|---|
| EFEMP2 increases the invasion ability of cervival cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway / / Na Li, Guo-Xin Ji, Zi-Yan Yang
|
|---|
| SNHG9/miR-214-5p/SOX4 feedback loop regulates osteosarcoma progression / / Chu-Jie Bai ... [et al.]
|
|---|
| NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis / / Chang-Sheng Wang ... [et al.]
|
|---|
| DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling / / Qing Han ... [et al.]
|
|---|
| IncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5 / / Fang Zhao ... [et al.]
|
|---|
| Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment / / Jing Chen ... [et al.]
|
|---|
| Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer.. / Yan Xu, Ji Zheng, Zhi-Ying Ye
|
|---|
| SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax / / Lu Liu ... [et al.]
|
|---|
| SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells / / Shi-Kang Deng ... [et al.]
|
|---|
| Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer / / Ke Ma, Yan-Xin Li, Qian-Qian Guo
|
|---|
| hsa_circ_0067514 suppresses gastric cancer progression and glycolysis via miR-654-3p/LATS2 axis / / Shao-Feng Jiang, Rong-Rong Li
|
|---|
| BRAF inhibition promotes ER stress-mediated cell death in uveal melanoma / / Yinu Zhao ... [et al.]
|
|---|
| HSPA5 repressed ferroptosis to promote colorectal cancer development by maintaining GPX4 stability / / Ronglin Wang ... [et al.]
|
|---|
| Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL / / Peng Wang ... [et al.]
|
|---|
| Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1/HSPB7 axis / / Hai-Quan Yue ... [et al.]
|
|---|
| Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer : minireview / / Xiao-Qiang Guo, Yu-Ming Hua
|
|---|
| CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity : minireview / / Martin Krejči ... [et al.]
|
|---|
| Exploring novel systemic therapies for pancreatic cancer: a review of emerging anti-PD-1/PD-L1 combination therapy : minireview / / He Zhang ... [et al.]
|
|---|
